Publications by authors named "Duygulu M"
Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung.
Rev Assoc Med Bras (1992)
September 2024
Article Synopsis
- The study explores the survival rates of patients with large cell neuroendocrine carcinoma of the lung, focusing on the Ki-67 proliferation index and other clinical characteristics.
- The research involved 38 patients and found that factors like age, tumor location, metastasis at diagnosis, and treatment received could impact overall survival rates, though not significantly statistically.
- It concludes that identifying specific subgroups with lower survival rates could aid in patient prognosis, but larger studies are necessary for more definitive insights.
Purpose: In advanced breast cancer, endocrine therapy is preferred in the absence of visceral crisis. Cyclin-dependent kinase inhibitors (CDKi) are the gold standards. The selection of subsequent treatments after CDKi treatment is still controversial, and the efficacy of everolimus (EVE) combinations is unknown.
View Article and Find Full Text PDFObjective: To evaluate the impact of CDK4/6 inhibitors on erythrocyte mean corpuscular volume (MCV) change and its possible correlation with progression-free survival (PFS) and overall survival (OS).
Study Design: Observational study. Place and Duration of the Study: Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras, Turkiye, between January 2020 and 2023.
Background: Inflammation occurring after vascular endothelial damage plays a role in thrombus formation. Changes in various blood parameters that develop after the inflammatory condition can be used as a marker to predict thrombus.
Aim: This study aimed to investigate the relationship between the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and portal vein thrombosis (PVT).